MLchartDataset catalogue

AT7519M

Term · Oncology and biomedicine · MLC-T-ONC-000775

A substance being studied in the treatment of some types of cancer. AT7519M blocks enzymes needed for cells to divide. It is a type of cyclin-dependent kinase inhibitor. Also called CDK inhibitor AT7519M.

Table 1. Record
IdentifierMLC-T-ONC-000775
FieldOncology and biomedicine
ExpansionsCDK inhibitor AT7519M
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-000775",
  "term": "AT7519M",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of some types of cancer. AT7519M blocks enzymes needed for cells to divide. It is a type of cyclin-dependent kinase inhibitor. Also called CDK inhibitor AT7519M.",
  "expansions": [
    "CDK inhibitor AT7519M"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/at7519m/"
}

Record 2,535 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.